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The CD1 family of cell surface glycoprotein has been demonstrated to be a third lineage of antigen-presenting
molecules for specific T cell responses. They present lipidic, glycolipidic antigen and hydrophobic peptide to T
cells. CD1d restricted T cells play a role in autoimmune disease and in tumor immunity. Transforming growth factor
b (TGFb), a member of the family of polypeptide growth factors synthetized by human keratinocytes, has inhibitory
effects on proliferation and differentiation of immune cells, especially on CD1d-restricted natural killer T cells.
These properties led us to investigate the role of TGFb in CD1d expression on dendritic cells (DC), which are known
to play a key role in initiation of the immune response. Here, we observed CD1d molecules on DC developed from
PBMC with GM-CSF and IL4 but not with GM-CSF, IL4 and TGFb for 7 d. RT-PCR and FACS analysis (mAb 42.1)
performed at various stages of differentiation on CD34þ HPC show that CD1d mRNA levels and CD1d molecule
expression at the cell surface decreased progressively during the differentiation process. Thus, while committing
DC-precursors differentiation toward the Langerhans cell (LC) pathway, TGFb likely inhibits CD1d transcription.
Therefore, LC freshly recovered from epidermal sheet were evaluated by ﬂow cytometry. In accordance with in vitro
observation, they did not expressed measurable levels of CD1d molecules at the cell membrane. Thus, TGFb
produced by keratinocytes contribute to selectively downregulate CD1d expression on intraepidermal-resident LC.
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CD1 comprises a family of non-polymorphic genes located
outside the major histocompatibility complex (MHC) which
encode proteins structurally related to MHC class I mole-
cules (Yu et al, 1989). In humans, five distinct b2-micro-
globulin associated proteins have been identified and
classified in separate groups based primarily on sequence
homology. CD1a, b and c (group 1) are expressed by thy-
mocytes, and professional antigen-presenting cells (APC)
such as dendritic cells (DC), activated monocytes and B
cells (Porcelli et al, 1998). CD1d (group 2), the most highly
conserved molecules among mammals, are more broadly
distributed on lymphoid and myeloid cells than group 1 CD1
molecules and are expressed on several other lineages in-
cluding hepatocytes, intestinal epithelial cells (Rodionov
et al, 2000) and keratinocytes. CD1e, recently described in
DC, may represent a third type of CD1 molecules with dif-
ferent functional properties (Ange´nieux et al, 2000).
CD1d-restricted T cell receptor natural killer T (NKT) cells
are important regulators of immune responses by generation
of chemokines, T helper 1 (TH1) and TH2 cytokines. NKT
cells are involved in various immune responses such as
bacterial infections, tumor rejection and suppression of auto-
immune disorders (Exley et al, 1998). IFNg is a TH1 cytokine
produced by NKT cells, whereas IL-4 and IL-10 are TH2
cytokines that antagonize TH1 responses. It is still unclear
how NKT cells can regulate functions of both TH1 and TH2
populations. Transforming growth factor (TGFb), a member
of the family of polypeptide growth factors synthetized by
human keratinocytes, has inhibitory effects on the prolifer-
ation and differenciation of immune cells, especially on
CD1d-restricted NKT cells. These properties led us to inves-
tigate the role of TGFb in the modulation of CD1d expression
on DC which are known to play a key role in the initiation of
immune responses. We previously reported that human ker-
atinocytes express CD1d (Bonish et al, 2000). Furthermore,
many studies have demonstrated CD1d expression on mon-
ocyte-derived dendritic and dermal dendrocytes (Spada et
al, 2000; Gerlini et al, 2001). Several subpopulations of DC
have been described in vitro which can be generated by
incubation with different cytokines combinations. We have
searched for the effect of cytokines present in the cutaneous
environment, and more specifically on CD1d expression
during DC differentiation process. Strikingly, we found that
TGFb modulates CD1d expression on CD34þ and mon-
ocyte-derived DC (Mo-DC), explaining why this protein is not
found on Langerhans cell (LC) of the epidermis.
Results and Discussion
TGFb decreases CD1d expression on LC and DC gen-
erated in vitro from monocytes LC-like and Mo-DC were
generated in vitro from monocytes with GM-CSF and IL4, or
with TGFb for LC-like as described (Geissmann et al, 1998).
CD1d mRNA expression was low in cells cultured with
GM-CSFþ IL4þTGFb whereas MoDC still express CD1d
(Fig 1A). To further confirmed this result, we performed flow
Abbreviations: DC, dentritic cell; LC, Langerhans cell; Mo-DC,
monocyte-derived DC; NKT, natural killer T; TGFb, transforming
growth factor
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cytometry analysis and showed that CD1d is express on
Mo-DC but not on LC-like (Fig 1B).
CD1d expression decreases along differentiation of
CD34þ hematopoietic progenitor cells toward LC LC
were generated from cord blood CD34þ HPC in the pres-
ence of GM-CSF, TNFa and TGFb. FACS analysis showed
that CD1d membrane expression decrease during differen-
tiation (day 5, 7, 14). CD1d expression was evaluated on
cord blood CD34þ HPC-derived LC at day 14 when the DC
expressed most of the markers of LC (CD1aþ , E-Cad-
herineþ , langerinþ ; CD14, CD83, CD86, Factor XI-
IIa; data not shown). No expression of CD1d was
detectable (Fig 2). In contrast to this down regulation, in
absence of TGFb, CD1d membrane expression on FACS
analysis and mRNA CD1d expression remained the same
along the culture (Fig 2). As described for some member of
the CD1 family, protein could be retained in intracellular
compartment. Thus, we analyzed CD1d mRNA level. cDNA
obtained from cells harvested at day 5, 7 and at day 14 (i.e.,
LC) were normalized to yield equivalent GAPDH PCR prod-
ucts. When LC were generated from CD34þ HPC in the
presence of GM-CSF, TNFa and TGFb, CD1d mRNA ex-
pression decreased progressively and very low levels were
observed at day 14. When TGFb was omitted, CD1d mRNA
expression levels remained constant. Thus, omitting TGFb
resulted in a decrease of DC with LC phenotype to 15% of
total cells, compared with 80% in the presence of TGFb
(Geissmann et al, 1998).
Ex vivo, LC do not express CD1d Finally, we analyzed
CD1d expression on LC obtained from ex vivo normal skin
donors undergoing breast reduction. On cytospins and
confocal microscopy, LC, which express CD1a do not ex-
press CD1d (double staining CD1a/CD1d, with mAb CD1d
42.1 (data not shown)). In this context, flow cytometry with
CD1d staining confirmed that fresh isolated LC (CD1aþ ) do
not express CD1d (Fig 3).
The data shown in the present study increase our current
understanding of the negative expression of CD1d on LC.
CD1d expression in skin is largely restricted to DC on de-
rmis and to keratinocytes in epidermis. CD1d plays an
important role in lipidic antigen presentation as well as
immune response to mycobacteria and tumors, so it was
possible that LC could express CD1d. It was very difficult to
proove that these cells do not express CD1d, because with
immunohistochemical process, keratinocytes that express
CD1d are all over these cells. Furthermore, its difficult to
obtain very pure LC from fresh skin; and LC obtained from
CD34þ cord blood or monocytes are not the reality be-
cause they are obtained in vitro. There was another problem
with various CD1d antigen: CD1d-PE had not good results
with Mo-DC and keratinocytes on flow cytometry; CD1d
27.1 cross-over with HLA-DR. We confirmed previous
studies that showed LC do not express LC but there was
no explanation, as other DC in dermis express CD1d.
CD34þ cord blood was cultured with or without TGFb,
then there was a population with TGFb ‘‘Langerhans like’’.
We show that TGFb downregulated CD1d expression on
these cells on flow cytometry and RT-PCR. The results were
the same with Mo-DC cultured with or without TGFb.
CD1d expression in skin is of potential interest for skin
biology as it is involved in the presentation of glycolipids to
NKT cells. It has been shown that a-galactosylceramide, a
synthetic acylphytoshingolipid is presented by CD1d to
NKT cells that have potent antitumor activity. Human epi-
dermis is rich in lipids and glycolipids, and a disturbance in
lipid production might lead to aberrant presentation of lipis
and glycolopids by CD1d molecules in inflammatory and
neoplastic skin conditions. CD1d expression has been
demonstrated on psoriatic KC. TGFb that is synthesized by
Figure 1
CD1d expression on Langerhans cells and dendritic cells gener-
ated in vitro from monocytes: TGFb decrease CD1d expression.
(A) Detection of CD1d mRNA in DC by RT-PCR: specimens were nor-
malized to yield equivalent GAPDH PCR products. The CD1d specific
signal was observed in all populations, but it was stronger in DC with-
out TGFb in culture. Marker molecular are shown (M). (B) Surface ex-
pression of CD1d molecules using flow cytometric analysis: the open
histograms show staining with anti-CD1d mAb (42.1). The solid histo-
grams show staining with an isotype-matched non-binding control
mAb. CD1d protein was not expressed on DC derived monocytes with
TGFb (Langerhans cells like) but there was a signal on DC derived
monocytes that have not TGFb on cultures, that are DDC.
Figure 2
CD1d expression along differentiation of
CD34þ hematopoietic progenitor cells to-
ward Langerhans cells. LC were generated
from CD34þ HPC in the presence of GM-CSF,
TNFa and TGFb. FACS analysis performed at
various stage of differentiation show that as
opposed to CD1a, CD1d molecule expression
at the cell surface decrease during the differ-
entiation process. When TGFb was omitted
CD1d membrane expression remained con-
stant. The open histograms show staining with
anti-CD1d mAb (CD1d 42.1) or anti-CD1a mAb
(NA1/34). The solid histograms show staining
with isotype-matched non-binding control
mAbs. Comparison of CD1d mRNA at various
stages of differentiation: the cDNA derived
from cells harvested at day 5, 7 and at day 14 (i.e., LC) were normalized to yield equivalent GAPDH PCR products. When LC were generated from CD34þ
HPC in the presence of GM-CSF, TNFa and TGFb1, CD1d mRNA expression decreased progressively and very low levels were obseved at day 14 in
differentiated LC. When TGFb was omitted, CD1d mRNA expression levels remained constant.
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keratinocytes could inhibit CD1d expression on LC. Fur-
thermore, TGFb which is present in fetal bovine serum (FBS)
serum used during the cultures may contribute to decreas-
ing CD1d expression.
Regulation of CD1d expression on LC have never been
studied, however it has been shown that CD1d expression
was downregulated by FBS on Mo-DC. In our culture, there
was always the same FBS concentration on all cases, and
there was only TGFb that change. Negative CD1d expres-
sion on LC is a strinking difference in comparison with
group 1 CD1 proteins such as CD1a that is strongly ex-
pressed on LC.
In conclusion, and as previously described, CD1d was
expressed on dermal DC and keratinocytes. Here we
showed that TGFb decrease the level of CD1d transcripts
on DC thus the protein expression.
Material and Methods
Antibodies and reagents Primary murine mAb was: CD1a-FITC
(clone NA1/34, IgG2a kappa, DAKO, Trappes, France). A mAb
raised against soluble recombinant CD1d-IgG2a fusion protein
was provided by Steve Porcelli: CD1d42. This mAb and the meth-
od to produce it have been previously described (Exley et al, 2000).
Recombinant human growth factors used in this study were
GM-CSF (2  106 U per mg, Sandoz, Rueil-Malmaison, France),
TNFa 1  107 U per mg, Genzyme, Cambridge, MA), IL4 and TGFb
both from R&D Systems. RPMI 1640 was supplemented with 2 mM
L-glutamine, 1% non-essential aminoacids, 1mM sodium pyruvate,
Hepes buffer, 500 U per mL penicillin, 500 mg per mL streptomycin
(all from Life Technologies) and 10% fetal calf serum (FCS). FCS
was heat-inactivated at 561C for 30 min.
Generation of cord blood CD34þ HPC-derived Langerhans
cells and fresh ex vivo LC Umbilical cord blood samples were
obtained after obtaining informed consent. Culture medium was
further supplemented with 200 U per mL GM-CSF, 50 U per mL
TNFa and TGFb1 (1 ng per mL). At day 6, TGFb1 was omitted for
half of the culture. On day 5, 7, 10, 14, cells were recovered and
subjected to further analysis: flow cytometry and RT-PCR analysis.
Generation of monocyte-derived dendritic cells and monocyte-
derived Langerhans cells Mo-DC were prepared as described
previously (Grassi et al, 1998). This procedure routinely resulted in
the recovery of CD14þ PBMC at a purity of 490%. Monocytes
isolated were then cultuted with medium containing GM-CSF (800
U per mL) and IL4 U per mL for 6 d. Half of the culture received
TGFb1 (1 ng per mL) to differenciate into LC (Geissmann et al,
1998). At day 6, cells were collected for flow cytometry and RT-PCR
analysis. Preparation of epidermal cell suspensions and enrichment
for LC was performed as described (Dezutter-Dambuyant et al, 1991).
RT-PCR Detection of CD1d mRNA was performed using RT-PCR.
Specific transcripts encoding CD1d were amplified by RT-PCR as
previously described (Bonish et al, 2000). Specific primers used
were: CD1d (sense: 50-TCACCCATACAGGCTTTGGGTA-30, anti-
sense 50-CCTCCAATAACTTCTTCCATGT-30). Control studies using
a variety of different templates demonstrated the reaction to be
specific for CD1d, with no detectable amplification of CD1a, -b, or
-c transcription under these conditions (data not shown). Tran-
scripts for the housekeeping gene GAPDH were amplified using
the following primers (sense: 50-GGTGAAGGTCGGTGTCAACG-30,
antisense 50-CAAAGTTGTCATGGATGACC-30) as a control to
standardize the amount of template for each reaction.
Flow cytometry Cells (about 1  105) were washed in cold phos-
phate-buffered saline (PBS) containing 2% FCS and incubated
with the relevant mAb in PBS for 30 min at 41C. For indirect staining
experiments, cells were incubated with FITC- or Phycoerythrin-
conjugated goat antimouse IgG for 30 min at 41C. Controls in-
cluded staining with an isotype-matched irrelevant mAb.
For CD1d simple staining, cells were incubated with mAb
CD1d42.1 and revealed with biotinylated goat antimouse IgGHþ L
(Zymed) and streptavidin-FITC (Zymed, San Francisco, CA, USA),
30 min at 41C. Cells were fixed with 1% paraformaldehyde in PBS
before analysis on a FACScan cytometer (Becton Dickinson,
Franklin, Lakes, NJ, USA).
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Figure 3
Ex vivo, LC do not express CD1d. Fresh Langerhans cells were ob-
tained from fresh normal skin donors. Staining on FACS analysis with
CD1d 42.1 was negative, and CD1a was overexpressed.
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